Novel Coronavirus (SARS-CoV-2/COVID-19)
A COVID-19 vaccine is likely coming soon. Whether it鈥檚 next month, at the end of the year or in early 2021, many scientific experts believe we will have one or more safe and effective vaccines to combat the deadly virus.
The Department of Health and Human Services (HHS) Oct. 22 issued a revision to its reporting requirements for providers that received Provider Relief Fund (PRF) payments. The notice includes revised data elements that recipients must submit for calendar years 2019 and 2020. Specifically, recipients鈥
Join AHA Board Chair Melinda Estes, M.D., for the seventh in a series of Leadership Rounds 鈥 short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes will joined by Kevin W. Sowers, President of the Johns Hopkins鈥
AHA Board Chair Melinda Estes, M.D., hosts a series of Leadership Rounds 鈥 short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. The seventh in the series featured Dr. Estes talking with Jim Skogsbergh, President and CEO of鈥
Three leadership capabilities consistently rise to the top when Andy Shin, chief operating officer for the AHA鈥檚 Center for Health Innovation, interviews hospital and health system leaders navigating the pandemic.
U.S. counties with more racial and ethnic minority residents, people living in crowded housing and other social vulnerabilities were more likely to become COVID-19 hotspots in June and July, according to a study released by the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention updated how it defines 鈥渃lose contact鈥 exposure to an individual infected with the COVID-19 virus to someone within 6 feet of the infected individual for 15 minutes or more cumulatively over a 24-hour period, rather than exposure within 6 feet for at鈥
State-licensed pharmacists and state-authorized pharmacy interns under their supervision may administer COVID-19 vaccines and tests authorized or licensed by the Food and Drug Administration, subject to certain requirements, the Department of Health and Human Services said in guidance.
Moderna Inc., announced the completion of enrollment for its COVID-19 vaccine phase 3 trial.
Jim Skogsbergh, president and CEO of Advocate Aurora Health, joined AHA Board Chair Melinda Estes, M.D., today to discuss COVID-19鈥檚 impact on health trends and key strategies for reimagining and innovating care during and beyond the pandemic.